Overview
Title
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Export of Food and Drug Administration-Regulated Products: Export Certificates
Agencies
ELI5 AI
The document is like a small fix from the FDA, where they changed a date from January 20 to January 21, to make sure everything stays correct in their paperwork about sending certain products to other countries.
Summary AI
The document is a correction notice from the Food and Drug Administration and the Health and Human Services Department. It relates to a previous notice about the export of FDA-regulated products, specifically changing a date in the document. The correction changes the date in the "DATES" section from January 20, 2021, to January 21, 2021. This update ensures that the information is accurate for those referencing the document.
Keywords AI
Sources
AnalysisAI
The document in question is a correction notice from the Food and Drug Administration (FDA) and the Health and Human Services Department. The notice pertains to an earlier publication that addressed matters concerning the export of FDA-regulated products. Specifically, this correction involves a minor yet vital change in the dates associated with the document.
General Summary
The correction notice, as found in the Federal Register, indicates a change from January 20, 2021, to January 21, 2021, in the "DATES" section of the previously published document. The change appears straightforward and aims to ensure the accuracy of information for those consulting the notice.
Significant Issues or Concerns
There are no notable issues or concerns arising from this correction notice. The alteration is limited to the adjustment of a single date, which simplifies the document's purpose and function. The correction notice neither discusses nor implies any other changes in the regulatory or procedural approaches concerning FDA-regulated product exports.
Impact on the Public
The primary impact of this notice on the general public is minimal. For the average citizen without direct involvement in the export of FDA-regulated products, the change of date is unlikely to carry substantial significance. For those in industries or roles affected by such documentation, this correction helps maintain alignment with compliance requirements by ensuring they have the correct deadline or date in their schedules.
Impact on Specific Stakeholders
Stakeholders primarily affected by this correction include exporters and businesses involved in the trade of FDA-regulated goods. Ensuring access to the correct date within official documentation reduces the risk of compliance infractions and assists in safeguarding against potential delay or disruption in export operations. This correction can be seen as beneficial, as it upholds clarity and precision in official communications.
In summary, while the document is fundamentally a simple date correction, it plays an essential role in preserving accuracy and maintaining regulatory alignment for affected stakeholders. The notice exemplifies the routine administrative adjustments that ensure the reliability and integrity of regulatory frameworks governing exported goods.
Issues
• The document is a correction notice and does not include any specific information on spending, so there's no assessment provided on wasteful spending.
• There is no indication of spending that favors particular organizations or individuals as the document is solely concerned with a date change.
• The language used in the correction notice is clear and straightforward, with a clear indication on where the correction needs to be made and what it involves.
• Since the document is a straightforward correction, there is no overly complex or difficult language present.
• No other issues or concerns are identified as the document solely revolves around a correction of the date in a previous notice.